Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aptevo Therapeutics

3.05
+0.02000.66%
Post-market: 3.01-0.0400-1.31%16:35 EDT
Volume:235.13K
Turnover:726.08K
Market Cap:9.83M
PE:0.00
High:3.18
Open:3.09
Low:3.01
Close:3.03
Loading ...
Jun 21, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
May 27, 2021

Major Issues Report

8-K - Current report
May 26, 2021

Major Issues Report

8-K - Current report
May 11, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 11, 2021

Major Issues Report

8-K - Current report
May 05, 2021

Correspondence

CORRESP [Cover] - Correspondence
Apr 28, 2021

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 31, 2021

Major Issues Report

8-K - Current report
Mar 31, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Dec 17, 2020

Correspondence

CORRESP [Cover] - Correspondence
Dec 14, 2020

Major Issues Report

8-K - Current report
Dec 14, 2020

Major Issues Report

8-K - Current report
Dec 02, 2020

Major Issues Report

8-K - Current report
Nov 30, 2020

Major Issues Report

8-K - Current report